foxo4-dri senolytic peptide mouse model 2024

foxo4-dri senolytic peptide mouse model 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound Molecular modelling of the FOXO4-TP53

Name: foxo4-dri senolytic peptide mouse model 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound Molecular modelling of the FOXO4-TP53
Brand: everengland.com
SKU: 49555948308
Price: 21.52 USD
Availability: InStock
Rating: 4.4734 (25 reviews)

Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect FOXO4 DRI Peptide 10 mg Targeting Cellular Senescence in Aging and Age Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine

SKU: 49555948308 · From everengland.com

4.5

USD21.52 USD55.52

Pay in 4 interest-free payments of $5.38 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

How IDUN Peptides Sources BPC-157 IDUN Peptides BPC-157 is synthesized via solid-phase peptide synthesis (SPPS) and independently verified to 99% purity by third-party analytical laboratory testing